Published by Iain Gilbert on 6th April 2021
(Sharecast News) - Immunodiagnostics group Oncimmune said on Tuesday that it had signed two separate agreements for the use of its newly developed and proprietary Infectious Disease panel with Roche Pharmaceuticals and Cedars-Sinai Medical Center.
URL: http://www.digitallook.com/dl/news/story/31753460/...